Skip to Content

Stericycle Inc

SRCL: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$34.00LpvmtBycqchp

Stericycle's Q2 Featured Solid Organic Revenue Growth and Sequential Margin Improvement

Business Strategy and Outlook

Since its founding in 1989, Stericycle has been extremely acquisitive, having acquired over 500 companies. On the surface, this acquisitive strategy led to a lengthy period of impressive growth and the firm built unmatched scale. However, acquisitions began to stray from Stericycle's core competencies and poor integration efforts caused inefficiencies to build. After decades of strong growth and profitability, Stericycle's financial performance began to deteriorate in 2017.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of SRCL so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center